Clinical trial
The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment
NCT03654573 is registered in ClinicalTrials.gov with CorFlow Therapeutics AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment
- Lead sponsor
- CorFlow Therapeutics AG
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 4, 2019
- Completion date
- December 18, 2024
- Enrollment
- 73 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
microvascular obstruction, stemi - st elevation myocardial infarction